V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007849 | 330004665 | 1.77 | 76.9 | Palliative (P) | 2018-08-11 | 2018-08-22 | Paclitaxel 7 day | N | Y | 330012915 | PACLITAXEL |
| 330007850 | 330004665 | 0 | 53.9 | Curative (C) | 2015-04-21 | 2015-04-28 | CARBOPLATIN + RT | N | N | 330012915 | CARBOPLATIN + RT |
| 330007851 | 330004665 | 1.77 | 78.4 | Palliative (P) | 2016-05-08 | 2016-05-08 | VAI (Ifos 3g/m2) | 02 | N | 330012915 | VAI |
| 330007852 | 330012816 | 1.82 | 46 | null | 2017-01-24 | 2017-02-11 | CARBOPLATIN + RT | 2 | Y | 330012923 | CARBOPLATIN + RT |
| 330007853 | 330004666 | 1.51 | 55.7 | Disease modification (D) | 2017-02-07 | 2017-02-13 | ALL UKALL2011 Std Int Maint A | N | N | 330012926 | UKALL2011 |
| 330007854 | 330010628 | 1.7 | 22.3 | Not known (9) | 2016-03-07 | 2016-03-12 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 330012929 | BENDAMUSTINE + RITUXIMAB |
| 330007855 | 330004668 | 1.58 | null | Palliative (P) | 2013-03-11 | 2013-03-14 | ALL UKALL2011 (ProtM-A) C PegAsp | N | N | 330012934 | UKALL2011 |
| 330007856 | 330004669 | 1.66 | 110 | Disease modification (D) | 2014-04-22 | 2014-07-05 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 330012935 | UKALL2011 |
| 330007857 | 330008544 | 1.69 | 65 | Palliative (P) | 2016-08-30 | 2017-03-20 | Carbo F | 02 | N | 330012936 | CARBO + FLUOROURACIL |
| 330007858 | 330010630 | null | 50.4 | null | 2013-05-12 | 2013-11-03 | CARBOPLATIN + RT | 02 | N | 330012948 | CARBOPLATIN + RT |
| 330007859 | 330010630 | 1.64 | 63.9 | Palliative (P) | 2014-08-03 | 2014-08-03 | CETUXIMAB + RT | N | N | 330012948 | CETUXIMAB + RT |
| 330007864 | 330004673 | 1.75 | 80.6 | Palliative (P) | 2016-05-10 | 2016-06-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012968 | CARBOPLATIN + PACLITAXEL |
| 330007865 | 330004673 | 1.74 | 9.7 | Palliative (P) | 2016-10-20 | 2016-10-24 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330012968 | CARBO + FLUOROURACIL |
| 330007866 | 330004674 | 1.6 | 12.7 | Adjuvant (A) | 2017-03-25 | 2017-04-10 | CARBOPLATIN + PACLITAXEL | 02 | Y | 330012974 | CARBOPLATIN + PACLITAXEL |
| 330007867 | 330004674 | null | 28 | Curative (C) | 2017-02-14 | 2017-04-25 | CARBOPLATIN + RT | N | Y | 330012974 | CARBOPLATIN + RT |
| 330007868 | 330004674 | 1.85 | 112 | Palliative (P) | 2016-09-30 | 2016-12-07 | ALL UKALL2011 Ind A Std Dex (PAsp) | 02 | N | 330012974 | UKALL2011 |
| 330007869 | 330004676 | 1.61 | 44 | Not known (9) | 2013-05-13 | 2013-06-04 | Cetuximab + Radiotherapy Maint | N | Y | 330012992 | CETUXIMAB + RT |
| 330007870 | 330008549 | 1.51 | 63.3 | Neo-adjuvant (N) | 2015-09-02 | 2016-04-01 | Cetuximab + Radiotherapy Maint | 02 | N | 330012994 | CETUXIMAB + RT |
| 330007871 | 330011795 | 1.61 | 15.2 | Palliative (P) | null | 2016-02-09 | CARBOPLATIN + RT | N | N | 330012994 | CARBOPLATIN + RT |
| 330007872 | 330004677 | 1.83 | 77 | null | 2015-08-14 | 2015-08-20 | Carboplatin+Fluorouracil 4 or 5 day | 99 | Y | 330012996 | CARBO + FLUOROURACIL |
| 330007873 | 330008550 | 1.51 | null | Palliative (P) | 2013-12-27 | 2013-12-28 | ALL UKALL2011 Maintenance C2 | 2 | N | 330012997 | UKALL2011 |
| 330007874 | 330010636 | 1.56 | 73.9 | Palliative (P) | null | 2015-08-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | null | 330012997 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007875 | 330004678 | 0 | 53.8 | Disease modification (D) | 2016-07-18 | 2016-12-05 | Paclitaxel (2 or 3 weekly) | N | N | 330013003 | PACLITAXEL |
| 330007876 | 330004681 | 0 | 50 | Curative (C) | 2014-03-22 | 2014-03-22 | VAI (Ifos 3g/m2) | 02 | N | 330013004 | VAI |
| 330007877 | 330008552 | 1.81 | 14.4 | Palliative (P) | 2017-04-14 | 2017-05-03 | EURAMOS TRIAL | Y | N | 330013004 | EURAMOS TRIAL |
| 330007878 | 330008552 | 1.8 | 72.4 | Curative (C) | 2016-06-27 | 2016-11-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330013004 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007879 | 330004683 | null | 75.7 | Disease modification (D) | 2015-10-24 | 2015-11-19 | BENDAMUSTINE + RITUXIMAB | 2 | Y | 330013032 | BENDAMUSTINE + RITUXIMAB |
| 330007880 | 330011798 | 1.57 | 63 | Palliative (P) | 2014-08-28 | 2014-08-28 | Carboplatin + Paclitaxel (3 weekly) | 2 | Y | 330013038 | CARBOPLATIN + PACLITAXEL |
| 330007881 | 330011798 | 1.7 | null | Palliative (P) | 2013-09-15 | 2013-09-26 | Carboplatin + Etoposide IV 3 day | N | N | 330013038 | CARBOPLATIN + ETOPOSIDE |
| 330007882 | 330004684 | 1.61 | null | Palliative (P) | 2017-04-24 | 2017-04-24 | EURAMOS TRIAL | N | N | 330013060 | EURAMOS TRIAL |
| 330007883 | 330004684 | 1.84 | 84 | Not known (9) | 2018-04-17 | 2018-04-18 | Cetuximab + Radiotherapy Load | 02 | N | 330013060 | CETUXIMAB + RT |
| 330007884 | 330004685 | 1.63 | 52 | Palliative (P) | 2016-03-31 | 2016-04-03 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013065 | CARBO + FLUOROURACIL |
| 330007885 | 330008555 | 1.72 | 65.7 | Curative (C) | 2016-09-28 | 2016-10-05 | ALL UKALL2011 IndB Std Dex (PegAsp) | 2 | N | 330013066 | UKALL2011 |
| 330007886 | 330004688 | 1.85 | 64.2 | Curative (C) | 2013-07-17 | 2014-03-01 | CARBOPLATIN + RT | 02 | N | 330013067 | CARBOPLATIN + RT |
| 330007887 | 330004689 | 1.68 | 98 | Curative (C) | null | 2016-12-14 | CARBOPLATIN + ETOPOSIDE | null | null | 330013074 | CARBOPLATIN + ETOPOSIDE |
| 330007888 | 330004690 | 1.87 | null | Curative (C) | 2017-10-16 | 2017-10-16 | CARBOPLATIN + RT | 01 | N | 330013074 | CARBOPLATIN + RT |
| 330007889 | 330008559 | 1.6 | 57.35 | Not known (9) | 2015-03-02 | 2015-03-03 | CARBOPLATIN + ETOPOSIDE | N | Y | 330013078 | CARBOPLATIN + ETOPOSIDE |
| 330007890 | 330010641 | 0 | 74 | Curative (C) | 2017-08-26 | 2017-09-06 | EURAMOS TRIAL | N | N | 330013082 | EURAMOS TRIAL |
| 330007891 | 330004692 | null | 41 | Palliative (P) | 2017-01-04 | 2017-01-08 | Carbo F | N | N | 330013082 | CARBO + FLUOROURACIL |
| 330007892 | 330004694 | 0 | 80 | null | 2017-06-27 | 2017-07-04 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013095 | CARBO + FLUOROURACIL |
| 330007893 | 330004695 | 1.8 | null | Curative (C) | 2016-11-30 | 2017-02-07 | Carboplatin + Etoposide IV 3 day | 2 | Y | 330013096 | CARBOPLATIN + ETOPOSIDE |
| 330007894 | 330008562 | null | 72.8 | Curative (C) | 2017-10-07 | 2017-10-07 | Cetuximab + Radiotherapy Maint | 2 | null | 330013097 | CETUXIMAB + RT |
| 330007895 | 330004697 | null | 73.6 | Palliative (P) | 2018-11-06 | 2018-12-04 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | 330013098 | CARBOPLATIN + PACLITAXEL |
| 330007896 | 330004698 | 1.63 | 63 | Neo-adjuvant (N) | 2015-09-28 | 2016-05-17 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330013098 | CARBO + FLUOROURACIL |
| 330007897 | 330004700 | 1.73 | 78 | Curative (C) | 2017-04-10 | 2017-04-16 | BENDAMUSTINE + RITUXIMAB | N | N | 330013106 | BENDAMUSTINE + RITUXIMAB |
| 330007898 | 330004701 | null | 70.1 | Curative (C) | 2016-10-26 | 2016-10-30 | ALL UKALL2011 Maintenance C3 | Y | null | 330013109 | UKALL2011 |
| 330007899 | 330004702 | 1.73 | 89 | Neo-adjuvant (N) | 2014-05-22 | 2014-08-16 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330013109 | CARBOPLATIN + PACLITAXEL |
| 330007900 | 330010642 | 1.73 | 109 | Adjuvant (A) | 2013-07-25 | 2013-07-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 330013112 | BENDAMUSTINE + RITUXIMAB |
| 330007901 | 330010642 | 1.64 | 55.7 | Palliative (P) | 2016-08-29 | 2016-11-16 | Carbo F | N | N | 330013112 | CARBO + FLUOROURACIL |
| 330007902 | 330012820 | 1.67 | 59 | Curative (C) | 2016-04-19 | 2016-04-22 | ALL UKALL2011 Ind A Std Dex (PAsp) | N | N | 330013122 | UKALL2011 |